Establishment of Serum Free Chemically Defined Culture Medium to Study the Interactions Between Colonic Myofibroblasts and Colorectal Cancer Cells
Main Article Content
Abstract
Introduction: A crucial factor in cell culture technology is the use of appropriate culture medium which can promote cell growth and cellular functions. Development of serum free chemically defined medium enables the research- ers to conduct the experiment in a more controlled manner. Myofibroblasts of the tumour microenvironment drive the colorectal carcinogenesis. In vitro study of the tumour-myofibroblast interaction using serum free medium may give a better insight into potential treatment for colorectal cancer (CRC) in the future. This study aims to establish serum free chemically defined medium to study the interplay between myofibroblast and CRC cells. Methods: A myofibroblast-specific serum free culture medium named as M-CIL, was developed to study the interactions between myofibroblasts and CRC cell lines in vitro. The influence of substrate (collagen type I) and subculturing of cells under incubation with M-CIL medium were also analysed. The effect of M-CIL medium on CRC cell growth also was stud- ied. Gene expression analysis using quantitative real time polymerase chain reaction on amine oxidase, copper containing 3 (AOC3) was conducted to investigate the effect of individual components of the medium on myofibroblasts. Results: M-CIL medium supports the proliferation of myofibroblasts and produce minimal effect on CRC cells’ growth. Our data also shows the influence of M-CIL components on gene expression in myofibroblasts. Conclusion: M-CIL culture medium, which was designed with known and defined components, proved to be a suitable alternative to complete medium (DMEM + 10% FBS) for co-culture experiments of myofibroblasts and CRC cell lines.
Downloads
Article Details
References
Yao T, Asayama Y. Animal-cell culture media: History, characteristics, and current issues. Reprod Med Biol. 2017; 16(2):99-117.
Rittié L, Fisher GJ. Isolation and culture of skin fibroblasts. Methods Mol Med. 2005; 117:83-98.
van der Valk J, Bieback K, Buta C, Cochrane B, Dirks WG, Fu J et al. Fetal Bovine Serum (FBS): Past - Present - Future. ALTEX. 2018; 35(1):99-118.
Fang CYWC, Fang CL, Chen WY, Chen CL. Long- term growth comparison studies of FBS and FBS alternatives in six head and neck cell lines. PLoS ONE. 2017; 12(6): e0178960.
van der Valk J, Gstraunthaler G. Fetal Bovine Serum (FBS) - A pain in the dish? Altern Lab Anim. 2017; 45(6):329-332.
Martin C, Piccini A, Chevalot I, Olmos E, Guedon E, Marc A. Serum-free media for mesenchymal stem cells expansion on microcarriers. BMC. 2015; 9(Suppl 9): P70.
Ejiri H, Nomura T, Hasegawa M, Tatsumi C, Imai M, Sakakibara S et al. Use of synthetic serum-free medium for culture of human dermal fibroblasts to establish an experimental system similar to living dermis. Cytotechnology. 2015; 67(3):507-514.
Kolkmann AM, Post MJ, Rutjens MAM, van Essen ALM, Moutsatsou P. Serum-free media for the growth of primary bovine myoblasts. Cytotechnology. 2020; 72(1):111-120.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424.
Fuhr L, Abreu M, Carbone A, El-Athman R, Bianchi F, Laukkanen MO et al. The interplay between colon cancer cells and tumour-associated stromal cells impacts the biological clock and enhances malignant phenotypes. Cancers (Basel). 2019; 11(7):988.
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002; 3(5):349-363.
Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells - what challenges do they pose? Nat Rev Drug Discov. 2014; 13(7):497-512.
Hsia LT, Ashley N, Ouaret D, Wang LM, Wilding J, Bodmer WF. Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers. Proc Natl Acad Sci USA. 2016; 113(15):E2162-E2171.
Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, Takemasa I et al. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res. 2007; 13(7):2082-2090.
Adegboyega PA, Mifflin RC, DiMari JF, Saada JI, Powell DW. Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps. Arch Pathol Lab Med. 2002; 126(7):829- 836.
Eberlein C, Rooney C, Ross SJ, Farren M, Weir HM, Barry ST. E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling. Oncogene. 2015; 34(6):704-716.
Jung S, Sen A, Rosenberg L, Behie LA. Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. Cytotherapy 2010; 12(5):637-657.
Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006; 1(3):1112-1116.
Cooke MJ, Phillips SR, Shah DS, Athey D, Lakey JH, Przyborski SA. Enhanced cell attachment using a novel cell culture surface presenting functional domains from extracellular matrix proteins. Cytotechnology. 2018 56(2):71-79.
Haley EM, Kim Y. The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture. Cancer Lett. 2014; 346(1):1-5.
Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 1994; 54(10):2582-2590.
Zhang L, Sun W, Wang J, Zhang M, Yang S, Tian Y et al. Mitigation effect of an FGF-2 peptide on acute gastrointestinal syndrome after high-dose ionizing radiation. Int J Radiat Oncol Biol Phys. 2010; 77(1):261-268.
Chijimatsu R, Ikeya M, Yasui Y, Ikeda Y, Ebina K, Moriguchi Y et al. Characterization of mesenchymal stem cell-like cells derived from human iPSCs via neural crest development and their application for osteochondral repair. Stem Cells Int. 2017; 2017:1960965.
Lin Y, Linask KL, Mallon B, Johnson K, Klein M, Beers J et al. Heparin promotes cardiac differentiation of human pluripotent stem cells in chemically defined albumin-free medium, enabling consistent manufacture of cardiomyocytes. Stem Cells Transl Med. 2017; 6(2):527-538.
Hang TC, Lauffenburger DA, Griffith LG, Stolz DB. Lipids promote survival, proliferation, and maintenance of differentiation of rat liver sinusoidal endothelial cells in vitro. Am J Physiol Gastrointest Liver Physiol. 2012; 302(3):G375-G388.
Chan D, Lamande SR, Cole WG, Bateman JF. Regulation of procollagen synthesis and processing during ascorbate-induced extracellular matrix accumulation in vitro. Biochem J. 1990; 269(1):175-181.
Thomas WR, Holt PG. Vitamin C and immunity: an assessment of the evidence. Clin Exp Immunol. 1978; 32(2):370-379.
Duarte TL, Lunec J. Review: When is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C. Free Radic Res. 2005; 39(7):671-686.
Hata R, Senoo H. L-ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissuelike substance by skin fibroblasts. J Cell Physiol. 1989; 138(1):8-16.
Tsutsumi K, Fujikawa H, Kajikawa T, Takedachi M, Yamamoto T, Murakami S. Effects of L-ascorbic acid 2-phosphate magnesium salt on the properties of human gingival fibroblasts. J Periodontal Res. 2012; 47(2):263-271.
Piersma B, Wouters OY, de Rond S, Boersema M, Gjaltema RAF, Bank RA. Ascorbic acid promotes a TGFβ1-induced myofibroblast phenotype switch. Physiol Rep. 2017; 5(17):e13324.
Olivier E, Soury E, Ruminy P, Husson A, Parmentier F, Daveau M et al. Fetuin-B, a second member of the fetuin family in mammals. Biochem J. 2000; 350(Pt 2):589-597.
Dziegielewska KM, Brown WM, Gould CC, Matthews N, Sedgwick JE, Saunders NR. Fetuin: an acute phase protein in cattle. J Comp Physiol B. 1992; 162(2):168-171.
Sakwe AM, Koumangoye R, Goodwin SJ, Ochieng J. Fetuin-A ({alpha}2HS-glycoprotein) is a major serum adhesive protein that mediates growth signaling in breast tumor cells. J Biol Chem. 2010; 285(53):41827-41835.
Lu L, Li T, Williams G, Petit E, Borowsky M, Walker WA. Hydrocortisone induces changes in gene expression and differentiation in immature human enterocytes. Am J Physiol Gastrointest Liver Physiol. 2011; 300(3):G425-G432.
Shiomi N, Watanabe K. Effects of hydrocortisone, glycerophosphate and retinol on the differentiation of mesenchymal stem cells and vascular endothelial cells to osteoblasts. J Biomed Sci Eng. 2014; 7(13):1056-1066.
Kanta J. Collagen matrix as a tool in studying fibroblastic cell behavior. Cell Adh Migr. 2015; 9(4):308-316.
Kellermann J, Haupt H, Auerswald EA, Müller-Ester W. The arrangement of disulfide loops in human alpha 2-HS glycoprotein. Similarity to the disulfide bridge structures of cystatins and kininogens. J Biol Chem. 1989; 264(24):14121-14128.
Schinke T, Amendt C, Trindl A, Pöschke O, Müller- Esterl W, Jahnen-Dechent W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem. 1996; 271(34):20789-20796.
Demetriou M, Binkert C, Sukhu B, Tenenbaum HC, Dennis JW. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J Biol Chem. 1996; 271(22):12755-12761.
Szweras M, Liu D, Partridge EA, Pawling J, Sukhu B, Clokie C et al. alpha 2-HS glycoprotein/ fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem. 2002; 277(22):19991-19997.
Wen FQ, Kohyama T, Sköld CM, Zhu YK, Liu X, Romberger DJ et al. Glucocorticoids modulate TGF-beta production by human fetal lung fibroblasts. Inflammation. 2003; 27(1):9-19.
Rautava S, Walker WA, Lu L. Hydrocortisone- induced anti-inflammatory effects in immature human enterocytes depend on the timing of exposure. Am J Physiol Gastrointest Liver Physiol. 2016; 310(11):G920-G929.
Boyd DD, Levine AE, Brattain DE, McKnight MK, Brattain MG. Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose. Cancer Res. 1998; 48(9):2469-2474.
Huschtscha L, Rozengurt E, Bodmer WF. Growth factor requirements of human colorectal tumour cells: relations to cellular differentiation. Eur J Cancer. 1991; 27(12):1680-1684.